Conversion From Tacrolimus (TAC) to Sirolimus (SLR)-Based Immunosuppression in Pediatric Liver Transplant Recipients: Indications and Efficacy

被引：0
|
作者：
Daniel, J. [1 ]
Fioravanti, V. [1 ]
Fischer, R. [1 ]
Hendrickson, R. [1 ]
Ricks, S. [1 ]
Davis, M. [1 ]
Andrews, W. [1 ]
机构：
[1] Univ Missouri, Childrens Mercy Hosp, Kansas City, MO 64108 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2014年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A491
引用
收藏
页码：239 / 240
页数：2
相关论文
共 50 条
  • [21] Incidence of allergic symptoms in pediatric liver transplant recipients treated with tacrolimus based immunosuppression
    Prabhakaran, K
    Lau, HT
    Wise, B
    Schwarz, K
    Colombani, PM
    PEDIATRICS, 1999, 104 (03) : 786 - 787
  • [22] Conversion from cyclosporine to tacrolimus based immunosuppression therapy in renal transplant recipients
    Backman, Lars
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 51 (04) : A33 - A33
  • [23] Conversion from cyclosporine to tacrolimus based immunosuppression thrapy in renal transplant recipients
    Backman, Lars A.
    TRANSPLANT INTERNATIONAL, 2007, 20 : 138 - 138
  • [24] Peripheral lymphocyte markers as surrogate measures of tacrolimus (TAC) immunosuppression in pediatric transplant recipients.
    Sindhi, R
    LeVasseur, R
    Magill, A
    Yost, M
    HEPATOLOGY, 2002, 36 (04) : 663A - 663A
  • [25] Immunosuppression Withdrawal in Liver Transplant Recipients on Sirolimus
    Levitsky, Josh
    Mathew, James M.
    Miller, Joshua
    Heinrichs, Jessica
    Huang, Xumei
    Abecassis, Michael M.
    HEPATOLOGY, 2016, 64 : 1A - 1A
  • [26] Immunosuppression Withdrawal in Liver Transplant Recipients on Sirolimus
    Levitsky, Josh
    Burrell, Bryna E.
    Kanaparthi, Sai
    Turka, Laurence A.
    Kurian, Sunil
    Sanchez-Fueyo, Alberto
    Lozano, Juan J.
    Demetris, Anthony
    Lesniak, Andrew
    Kirk, Allan D.
    Stempora, Linda
    Yang, Guang-Yu
    Mathew, James M.
    HEPATOLOGY, 2020, 72 (02) : 569 - 583
  • [27] Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipients
    Levitsky, Josh
    Mathew, James M.
    Abecassis, Michael
    Tambur, Anat
    Leventhal, Joseph
    Chandrasekaran, Dhivya
    Herrera, Nancy
    Al-Saden, Patrice
    Gallon, Lorenzo
    Abdul-Nabi, Anmaar
    Yang, Guang-Yu
    Kurian, Sunil M.
    Salomon, Daniel R.
    Miller, Joshua
    HEPATOLOGY, 2013, 57 (01) : 239 - 248
  • [28] Safety Profile After Planned Conversion From Tacrolimus (TAC) to Sirolimus (SRL) Based Immunosuppressive Therapy in Kidney Transplant Recipients (KTR)
    Felix, M.
    Felipe, C.
    Tedesco, H.
    Medina-Pestana, J.
    TRANSPLANTATION, 2014, 98 : 544 - 545
  • [29] Safety Profile After Planned Conversion From Tacrolimus (TAC) to Sirolimus (SRL) Based Immunosuppressive Therapy in Kidney Transplant Recipients (KTR)
    Felix, M.
    Felipe, C.
    Tedesco, H.
    Medina-Pestana, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 544 - 545
  • [30] Safety and Efficacy of Conversion to Once-Daily Tacrolimus from Twice-Daily Tacrolimus in Pediatric Liver Transplant Recipients
    An, Sunghyo
    Lee, Sanghoon
    Rhu, Jinsoo
    Kim, Jong Man
    Choi, Gyu-Seong
    Joh, Jae-Won
    JOURNAL OF PEDIATRIC SURGERY, 2023, 58 (10) : 2054 - 2058
12345